Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.
Chesney MA. Chesney MA. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S149-55. doi: 10.1097/01.qai.0000243112.91293.26. J Acquir Immune Defic Syndr. 2006. PMID: 17133199
Adherence: a necessity for successful HIV combination therapy.
Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Chesney MA, et al. AIDS. 1999;13 Suppl A:S271-8. AIDS. 1999. PMID: 10885784 Review.
Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.
Chesney MA, Chambers DB, Kahn JO. Chesney MA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):266-71. doi: 10.1097/00042560-199712010-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9402073
Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.
Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Roland ME, et al. J Infect Dis. 2001 Dec 15;184(12):1608-12. doi: 10.1086/324580. Epub 2001 Dec 3. J Infect Dis. 2001. PMID: 11740738
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH. Kahn JO, et al. J Infect Dis. 2001 Mar 1;183(5):707-14. doi: 10.1086/318829. Epub 2001 Feb 1. J Infect Dis. 2001. PMID: 11181146
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.
Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, Friedland G; Terry Beirn Community Programs for Clinical Research on AIDS. Mannheimer SB, et al. AIDS Care. 2005 Jan;17(1):10-22. doi: 10.1080/09540120412331305098. AIDS Care. 2005. PMID: 15832830 Clinical Trial.
Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
Lurie P, Miller S, Hecht F, Chesney M, Lo B. Lurie P, et al. JAMA. 1998 Nov 25;280(20):1769-73. doi: 10.1001/jama.280.20.1769. JAMA. 1998. PMID: 9842953
Provider assessment of adherence to HIV antiretroviral therapy.
Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Bangsberg DR, et al. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):435-42. doi: 10.1097/00126334-200104150-00005. J Acquir Immune Defic Syndr. 2001. PMID: 11391162
Helping the urban poor stay with antiretroviral HIV drug therapy.
Bamberger JD, Unick J, Klein P, Fraser M, Chesney M, Katz MH. Bamberger JD, et al. Am J Public Health. 2000 May;90(5):699-701. doi: 10.2105/ajph.90.5.699. Am J Public Health. 2000. PMID: 10800416 Free PMC article.
Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial.
Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR. Tulsky JP, et al. Arch Intern Med. 2000 Mar 13;160(5):697-702. doi: 10.1001/archinte.160.5.697. Arch Intern Med. 2000. PMID: 10724056 Clinical Trial.
190 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback